• 1
    Jurga, F. and Morrison, S.E. (2004) Maggot debridement therapy. Alternative therapy for hoof infection and necrosis. Hoofcare & Lameness 78, 28-31.
  • 2
    Dumville, J.C., Worthy, G., Bland, J.M., Cullum, N., Dowson, C., Iglesias, C., Mitchell, J.L., Nelson, E.A., Soares, M.O. and Torgerson, D.J. (2009) Larval therapy for leg ulcers (VenUS II): randomised controlled trial. Br. Med. J. 19, 338-344.
  • 3
    Morrison, S.E. (2005) How to use sterile maggot debridement therapy for foot infections of the horse. Proc. Am. Ass. Equine Practnrs. 51, 461-464.
  • 4
    Lepage, O.M., Robert, M. and Doumbia, A. (2008) Biosurgery – the comeback of maggot debridement. Proceedings 14th ESVOT Congress 14, 255-257.
  • 5
    Casu, R.E., Pearson, R.D., Jamey, J.M., Cadogan, L.C., Riding, G.A. and Tellam, R.L. (1994) Excretory/secretory chymotrypsin from Lucilia Cuprina: purification, enzymatic specificity and amino acid sequence deduced from mRNA. Insect Mol. Biol. 3, 201-211.
  • 6
    Daeschlein, G., Mumcuoglu, K.Y., Assadian, O., Hoffmeister, B. and Kramer, A. (2007) In vitro antibacterial activity of Lucilia sericata maggot secretions. Skin Pharmacol. Physiol. 20, 112-115.
  • 7
    Prete, P.E. (1997) Growth effects of Phaenicia sericata larval extracts on fibroblasts: mechanism for wound healing by maggot therapy. Life Sci. 60, 505-510.
  • 8
    Cazander, G., Veen, K.E., Bouwman, L.H., Bernards, A.T. and Jukema, G.N. (2009) The influence of maggot excretions on PAO1 biofilm formation on different biomaterials. Clin. Orthop. Relat. Res. 467, 536-545.
  • 9
    Cazander, G., van de Veerdonk, M., Vandenbroucke-Grauls, C., Schreurs, M. and Jukema, G. (2010) Maggot excretions inhibit biofilm formation on biomaterials. Clin. Orthop. Relat. Res. 468, 2789-2796.
  • 10
    Bell, N. and Thomas, S. (2001) Use of sterile maggots to treat panniculitis in an aged donkey. Vet. Rec. 149, 768-770.
  • 11
    Fleischmann, W., Grassberger, M. and Sherman, R. (2004) Maggot Therapy: A Handbook of Maggot-Assisted Wound Healing, Georg Thieme Verlag, Stutgart. p 85.
  • 12
    Bras, R.J. and Morrison, S. (2009) Retrospective case series of 20 horses (2002-2009) sustaining puncture wounds to the navicular bursa with maggot debridement therapy as an adjunctive treatment. Proc. Am. Ass. Equine Practnrs. 55, 241-250.
  • 13
    Pearson, C. (2007) Something old is new again: debriding and reducing local wound infection with maggots. Clin. Pract. Wound Care Can. 5, 22-26.
  • 14
    Lodge, A., Jones, M. and Thomas, S. (2006) Maggots ‘n’ chips: a novel approach to the treatment of diabetic ulcers. Br. J. Community Nurs. Suppl. 11, 23-26.
  • 15
    Steenvoorde, P., Jacobi, C.E. and Oskam, J. (2005) Maggot debridement therapy: free-range or contained? An in-vivo study. Adv. Skin Wound Care 18, 430-435.
  • 16
    Bexfield, A., Nigam, Y., Thomas, S. and Ratcliffe, N.A. (2004) Detection and partial characterization of two antibacterial factors from the excretions/secretions of the medicinal maggot Lucilia sericata and their activity against methicillin-resistant Staphylococcus aureus (MRSA). Microbes Infect. 6, 1297-1304.
  • 17
    Jaklič, D., Lapanje, A., Zupančič, K., Smrke, D. and Gunde-Cimerman, N. (2008) Selective antimicrobial activity of maggots against pathogenic bacteria. J. Med. Microbiol. 57, 617-625.
  • 18
    Cazander, G., Pawiroredjo, J.S., Vandenbroucke-Grauls, C.M.J., Schreurs, M.W.J. and Jukema, G.N. (2010) Synergism between maggot excretions and antibiotics. Wound Repair Regen. 18, 637-642.